blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2716648

EP2716648 - ISOXAZOLIDINE DERIVATIVES [Right-click to bookmark this link]
Former [2014/15]Isoxazolidine derivatives
[2017/06]
StatusNo opposition filed within time limit
Status updated on  20.04.2018
Database last updated on 03.10.2024
FormerThe patent has been granted
Status updated on  12.05.2017
FormerGrant of patent is intended
Status updated on  15.01.2017
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
CHIESI FARMACEUTICI S.p.A.
Via Palermo, 26/A
43100 Parma / IT
[2014/15]
Inventor(s)01 / Ghidini, Eleonora
c/o CHIESI FARMACEUTICI S.p.A.
Via Palermo, 26/A
43100 PARMA / IT
02 / Rizzi, Andrea
c/o CHIESI FARMACEUTICI S.p.A
Via Palermo, 26/A
43100 PARMA / IT
 [2014/15]
Representative(s)Minoja, Fabrizio
Bianchetti & Minoja S.r.l.
Via Plinio, 63
20129 Milano / IT
[N/P]
Former [2017/24]Minoja, Fabrizio
Bianchetti Bracco Minoja S.r.l.
Via Plinio, 63
20129 Milano / IT
Former [2014/15]Minoja, Fabrizio
Bianchetti Bracco Minoja S.r.l. Via Plinio, 63
20129 Milano / IT
Application number, filing date13197855.314.03.2012
[2014/15]
Priority number, dateEP2011015823015.03.2011         Original published format: EP 11158230
[2014/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2716648
Date:09.04.2014
Language:EN
[2014/15]
Type: B1 Patent specification 
No.:EP2716648
Date:14.06.2017
Language:EN
[2017/24]
Search report(s)(Supplementary) European search report - dispatched on:EP11.03.2014
ClassificationIPC:C07J71/00, A61K31/58, A61P5/44, A61P11/06, A61P37/08
[2014/15]
CPC:
C07J71/0068 (EP,US); C07J71/00 (KR); A61K31/58 (EP,KR,US);
A61K45/06 (US); A61P11/00 (EP); A61P11/06 (EP);
A61P11/08 (EP); A61P29/00 (EP); A61P37/08 (EP);
A61P5/44 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/24]
Former [2014/15]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
Extension statesBA30.09.2014
ME30.09.2014
TitleGerman:ISOXAZOLIDIN-DERIVATE[2017/03]
English:ISOXAZOLIDINE DERIVATIVES[2017/06]
French:DÉRIVÉS D'ISOXAZOLIDINE[2017/03]
Former [2014/16]Isoxazolidin-Derivate
Former [2014/15]Isoxazolidine derivatives
Former [2014/16]Dérivés d'isoxazolidine
Examination procedure30.09.2014Amendment by applicant (claims and/or description)
30.09.2014Examination requested  [2014/46]
19.11.2014Despatch of a communication from the examining division (Time limit: M04)
05.03.2015Reply to a communication from the examining division
30.07.2015Despatch of a communication from the examining division (Time limit: M02)
09.10.2015Reply to a communication from the examining division
16.01.2017Communication of intention to grant the patent
05.05.2017Fee for grant paid
05.05.2017Fee for publishing/printing paid
05.05.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP12711601.0  / EP2686332
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20120711601) is  27.07.2015
Opposition(s)15.03.2018No opposition filed within time limit [2018/21]
Fees paidRenewal fee
13.01.2014Renewal fee patent year 03
27.03.2015Renewal fee patent year 04
31.03.2016Renewal fee patent year 05
27.03.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU14.03.2012
AL14.06.2017
AT14.06.2017
CY14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
MK14.06.2017
NL14.06.2017
PL14.06.2017
PT14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
IE14.03.2018
LU14.03.2018
MT14.03.2018
[2020/34]
Former [2020/31]HU14.03.2012
AT14.06.2017
CY14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
MK14.06.2017
NL14.06.2017
PL14.06.2017
PT14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
IE14.03.2018
LU14.03.2018
MT14.03.2018
Former [2020/27]HU14.03.2012
AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
PT14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
IE14.03.2018
LU14.03.2018
MT14.03.2018
Former [2020/08]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
IE14.03.2018
LU14.03.2018
MT14.03.2018
Former [2019/09]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
IE14.03.2018
LU14.03.2018
Former [2019/04]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
LU14.03.2018
Former [2018/52]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
MC14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/39]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SI14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/21]AT14.06.2017
CZ14.06.2017
DK14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/11]AT14.06.2017
CZ14.06.2017
EE14.06.2017
ES14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
PL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SK14.06.2017
SM14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
IS14.10.2017
Former [2018/10]AT14.06.2017
CZ14.06.2017
EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
RO14.06.2017
RS14.06.2017
SE14.06.2017
SK14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2018/09]EE14.06.2017
FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
RS14.06.2017
SE14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2017/52]FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
NL14.06.2017
RS14.06.2017
SE14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2017/50]FI14.06.2017
HR14.06.2017
LT14.06.2017
LV14.06.2017
RS14.06.2017
SE14.06.2017
BG14.09.2017
NO14.09.2017
GR15.09.2017
Former [2017/49]FI14.06.2017
HR14.06.2017
LT14.06.2017
NO14.09.2017
GR15.09.2017
Documents cited:Search[I]US3631033  (NATHANSOHN GIANGIACOMO, et al) [I] 1-13 * the whole document *;
 [I]WO2006005611  (NOVARTIS AG [CH], et al) [I] 1-13 * the whole document * * in particular examples 1-3, 6 and 7 *;
 [I]WO2009069032  (PFIZER LTD [GB], et al) [I] 1-13 * the whole document * * see examples 1-5 and in particular examples 6 and 7 *;
 [I]WO2009108118  (ASTRAZENECA AB [SE], et al) [I] 1-13 * the whole document * * in particular examples 5,6,17-31, 36-44 and Table 1 *;
 [XPI]WO2011029547  (CHIESI FARMA SPA [IT], et al) [XP] 1-6,8-13 * the whole document * * in particular claim 1 * [I] 7;
 [IP]WO2011095535  (CHIESI FARMA SPA [IT], et al) [IP] 1-13 * the whole document ** in particular compounds 111-117 *;
 [I]  - GREEN M J ET AL, "Synthesis and topical antiinflammatory activity of some steroidal [16 alpha, 17 alpha-d]Isoxazolidines", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19821201), vol. 25, no. 12, doi:10.1021/JM00354A020, ISSN 0022-2623, pages 1492 - 1495, XP002351702 [I] 1-13 * the whole document * * in particular abstract and table 1: examples 17, 19 *

DOI:   http://dx.doi.org/10.1021/jm00354a020
 [I]  - GIRDHAR N K ET AL, "Regio- and stereoselective thermal cycloaddition of alpha-aryl-N-phenylnitrones to 16-dehydropregnenolone acetate: pi-facial selective addition of the minor rotamers of the nitrones", TETRAHEDRON LETTERS, ELSEVIER, AMSTERDAM, NL, (20000923), vol. 41, no. 39, doi:10.1016/S0040-4039(00)01294-6, ISSN 0040-4039, pages 7551 - 7554, XP004217348 [I] 1-13 * abstract *

DOI:   http://dx.doi.org/10.1016/S0040-4039(00)01294-6
by applicantGB1578446
 WO2006005611
 WO2006074187
 WO2011029547
    - J. MED. CHEM., (1982), vol. 25, pages 1492 - 1495
    - J. MED. CHEM., (1995), pages 379 - 388
    - J. C. S. CHEM. COMM., (1985), pages 256 - 257
    - BIOORG. MED. CHEM. LETT., (2005), page 2834
    - J.MED. CHEM., (1982), vol. 25, pages 1492 - 1495
    - J. MED. CHEM., (1997), vol. 40, pages 1955 - 1968
    - CHEM.PHARM.BULL., (1998), vol. 46, pages 966 - 972
    - TETRAHEDRON, (1994), vol. 50, pages 13165 - 13172
    - MARCH'S, Advanced Organic Chemistry, WILEY-INTERSCIENCE
    - J. ORG. CHEM., (1999), vol. 1042
    - J.STEROID.BIOCHEM., (1980), vol. 13, pages 311 - 322
    - J. MED. CHEM., (1994), vol. 37, pages 3717 - 3729
    - TETRAHEDRON, (1992), vol. 47, no. 17, pages 3557 - 3570
    - J.A.C.S., (2005), vol. 127, no. 29, page 10396
    - J.A.C.S., (2000), vol. 122, no. 18, page 4522
    - TETRAHEDRON, (1999), vol. 55, no. 41, page 12069
    - ORGANIC LETTERS, (2002), vol. 4, no. 15, page 2485
    - SYNTHETIC COMMUNICATIONS, (1997), vol. 27, no. 20, pages 3497 - 3504
    - SYNTHESIS, (1984), vol. 11, pages 938 - 941
    - TETRAHEDRON LETTERS, (2005), vol. 46, no. 35, pages 5913 - 5918
    - JOC, (1982), vol. 47, no. 7, page 1171
    - J. MED. CHEM., (2009), vol. 52, no. 19, page 5974
    - AM. J. RESPIR. CRIT. CARE MED., (2000), vol. 162, pages 1455 - 1461
    - DRUG DEVEL.TECHNOL., (2006), vol. 4, no. 3, pages 263 - 272
    - J. NEUROIMMUNOL., (2004), vol. 150, pages 29 - 36
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.